Susceptibility to audiogenic stimuli induced by hyperbaric oxygenation and various neuroactive agents.
D006916:5-Hydroxytryptophan / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001285:Atropine / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology* / Q000627:therapeutic use; D010134:Fenclonine / Q000494:pharmacology / Q000627:therapeutic use; D006931:Hyperbaric Oxygenation; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine / Q000494:pharmacology* / Q000627:therapeutic use; D012640:Seizures / Q000517:prevention & control; D013016:Sound; D009435:Synaptic Transmission / Q000187:drug effects*; D014443:Tyrosine
D018377:Neurotransmitter Agents; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D001285:Atropine; D012110:Reserpine; D010830:Physostigmine; D006916:5-Hydroxytryptophan; D006899:Mixed Function Oxygenases; D010134:Fenclonine